Clinical Trial Update: An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study

View source ↗

Summary

An observational study (DiRECT) enrolling cancer patients treated with immune checkpoint inhibitors to observe outcomes in hematologic malignancies and solid tu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy
• Malignant Solid Neoplasm

Snippet

Sponsor: University of Rochester NCORP Research Base | Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Status: ACTIVE_NOT_RECRUITING